Clinical Research Directory
Browse clinical research sites, groups, and studies.
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Chronic Kidney Disease (CKD)
Sponsor: NYU Langone Health
Summary
30 patients will participate in a prospective randomized clinical trial to test the safety, tolerability and efficacy of transcutaneous auricular vagus nerve stimulation (taVNS) for autonomic nervous system (ANS) dysfunction in the chronic kidney disease (CKD) stage 3-5 setting.
Official title: A Randomized, Sham-controlled Pilot Trial of a Novel Therapeutic Strategy (taVNS) for Autonomic Nervous System (ANS) Dysfunction in Chronic Kidney Disease (CKD)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2025-10-15
Completion Date
2029-01-31
Last Updated
2025-12-31
Healthy Volunteers
No
Conditions
Interventions
Active taVNS
Active taVNS delivered via the TENS Device 7000.
Sham taVNS
Sham taVNS delivered via the TENS Device 7000.
Locations (1)
NYU Langone Health
New York, New York, United States